🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/04/2015 43,75 44,68 43,16 43,62 -0,11% 3,47% 516.700
13/04/2015 42,96 45,09 42,96 43,67 +2,25% 4,96% 642.200
10/04/2015 42,01 43,29 41,62 42,71 +1,84% 3,98% 475.900
09/04/2015 42,02 42,75 40,51 41,94 -0,36% 5,33% 593.800
08/04/2015 40,16 42,15 39,70 42,09 +4,70% 6,10% 736.500
07/04/2015 39,20 41,19 39,14 40,20 +2,81% 5,23% 666.800
06/04/2015 39,44 40,02 38,94 39,10 -1,06% 2,74% 625.400
02/04/2015 39,74 40,80 38,72 39,52 -0,95% 5,23% 665.800
01/04/2015 40,51 41,54 38,30 39,90 +0,48% 8,00% 981.100
31/03/2015 41,08 41,94 38,91 39,71 -4,38% 7,38% 1.531.900
30/03/2015 40,75 43,00 39,80 41,53 +7,09% 7,85% 1.330.900
27/03/2015 37,40 39,23 37,40 38,78 +3,88% 4,89% 1.057.000
26/03/2015 35,61 37,49 35,06 37,33 +2,64% 6,82% 1.717.300
25/03/2015 41,77 41,77 36,28 36,37 -11,34% 13,14% 2.251.000
24/03/2015 41,72 42,58 40,88 41,02 -1,56% 4,07% 973.200
23/03/2015 43,29 43,59 40,75 41,67 -4,43% 6,56% 1.906.900
20/03/2015 44,86 45,36 43,57 43,60 -1,47% 3,99% 2.679.000
19/03/2015 43,19 45,00 43,12 44,25 +4,14% 4,35% 1.392.200
18/03/2015 42,53 43,04 42,10 42,49 -0,09% 2,21% 915.200
17/03/2015 41,83 42,69 41,50 42,53 +1,48% 2,84% 673.300
16/03/2015 41,37 41,94 40,84 41,91 +2,32% 2,66% 655.900
13/03/2015 40,64 41,98 40,53 40,96 +1,26% 3,57% 964.300
12/03/2015 40,94 41,48 40,13 40,45 -0,20% 3,30% 804.800
11/03/2015 40,69 40,89 39,77 40,53 +0,22% 2,75% 737.000
10/03/2015 39,02 41,27 39,02 40,44 +1,97% 5,77% 1.027.100
09/03/2015 40,64 40,65 39,04 39,66 -2,48% 3,96% 785.000
06/03/2015 40,67 41,24 39,93 40,67 -0,61% 3,22% 1.167.700
05/03/2015 41,43 42,38 40,83 40,92 -0,85% 3,74% 1.043.500
04/03/2015 41,71 41,83 40,36 41,27 +1,00% 3,52% 1.103.700
03/03/2015 40,44 40,94 39,38 40,86 +1,06% 3,86% 1.136.700